.After antibody-drug conjugate (ADC) expert Seagen was offered to Pfizer in 2015 for a massive $43 b...
.On the heels of a phase 3 succeed that fell short to wow capitalists, Ironwood Pharmaceuticals is b...
.Don't stop Monte Rosa Rehabs currently. The Boston-based biotech is actually enjoying after signing...
.Invite to this week's Chutes & Ladders, our roundup of notable leadership hirings, firings and a...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang the...
.AbbVie has gone back to the source of its own antipsychotic giant Vraylar in search of yet another ...
.GenSight Biologics is actually full weeks far from lacking funds. Again. The biotech merely possess...
.Monopar Therapies is recouping a drug from the dump of AstraZeneca's uncommon disease pipe. It has ...
.Along with brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of p...
.After developing a genetics therapy relationship along with Dyno Rehabs in 2020, Roche is back for ...